Observational trials in pulmonary arterial hypertension: low scientific evidence but high clinical value
- PMID: 17329488
- DOI: 10.1183/09031936.00001607
Observational trials in pulmonary arterial hypertension: low scientific evidence but high clinical value
Comment on
-
Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.Eur Respir J. 2007 Mar;29(3):469-75. doi: 10.1183/09031936.00081706. Epub 2006 Nov 1. Eur Respir J. 2007. PMID: 17079256
Similar articles
-
[The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].Rev Med Interne. 2007 Dec;28 Suppl 4:S273-6. doi: 10.1016/j.revmed.2007.09.012. Epub 2007 Oct 8. Rev Med Interne. 2007. PMID: 17961866 French. No abstract available.
-
Sildenafil in the treatment of pulmonary hypertension.Vasc Health Risk Manag. 2006;2(4):411-22. doi: 10.2147/vhrm.2006.2.4.411. Vasc Health Risk Manag. 2006. PMID: 17323595 Free PMC article. Review.
-
Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.Eur Respir J. 2007 Mar;29(3):469-75. doi: 10.1183/09031936.00081706. Epub 2006 Nov 1. Eur Respir J. 2007. PMID: 17079256
-
Sildenafil citrate for the treatment of pulmonary hypertension.Drugs Today (Barc). 2006 Dec;42(12):771-84. doi: 10.1358/dot.2006.42.12.1032057. Drugs Today (Barc). 2006. PMID: 17285150 Review.
-
Sildenafil for pulmonary hypertension in ARDS: a new pleasant effect?Intensive Care Med. 2010 May;36(5):729-31. doi: 10.1007/s00134-010-1771-2. Epub 2010 Feb 4. Intensive Care Med. 2010. PMID: 20130829 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical